GLEN ALLEN, Va., March 24, 2026 (GLOBE NEWSWIRE)-- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of ...
Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results